If you liked this article you might like

Actelion is a Perfect Fit for Sanofi but Probably too Expensive: Exane BNP
5 Things You Must Know Before the Market Opens Tuesday
European Stocks Slip Lower, Italy Gains in Mixed Start to Trading
Actelion Surges on Report of Sanofi Challenge to J&J Takeover Bid